18F FES-PET/MRI for Tailoring Treatment of Luminal A and Lobular Breast Cancer
Conditions: Breast Cancer Female; Lobular Breast Carcinoma; PET/MRI; Axillary Staging; Luminal A Breast Cancer Interventions: Drug: FES; Procedure: PET/MRI A; Procedure: PET/MRI B; Procedure: PET/MRI C; Procedure: PET/MRI D; Genetic: Translational analysis Sponsors: IRCCS San Raffaele; Associazione Italiana per la Ricerca sul Cancro Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2023 Category: Research Source Type: clinical trials
Olaparib and Alpelisib for Treatment of Metastatic Breast Cancer, A ComboMATCH Treatment Trial
Conditions: Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IV Breast Cancer AJCC v8; Metastatic HER2-Negative Breast Carcinoma; Unresectable HER2-Negative Breast Carcinoma Interventions: Drug: Alpelisib; Procedure: Biopsy; Procedure: Biospecimen Collection; Procedure: Bone Scan; Procedure: Computed Tomography; Procedure: Magnetic Resonance Imaging; Drug: Olaparib; Procedure: Positron Emission Tomography Sponsor: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
Conditions: Metastatic Breast Cancer; Lobular Breast Carcinoma Intervention: Procedure: Blood Specimen Sponsor: University of California, San Francisco Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2023 Category: Research Source Type: clinical trials
SCOUT ® Radar Localization in Nonpalpable Breast Lesions
Conditions: Breast Cancer; Occult Breast Carcinoma Intervention: Device: SCOUT® Radar occult breast lesion Localization Sponsor: European Institute of Oncology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2023 Category: Research Source Type: clinical trials
